登录 注册 会员服务 联系我们

Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria

  • Published:2016-06-10 Issue: Volume:30 Page:25-32
  • ISSN:0926-9959
  • Container-title:Journal of the European Academy of Dermatology and Venereology
  • language:en
  • Short-container-title:J Eur Acad Dermatol Venereol

Author:

Giménez-Arnau A. M.1,Toubi E.2,Marsland A. M.3,Maurer M.4

Affiliation:

1. Department of Dermatology; Hospital del Mar; Universitat Autònoma de Barcelona; Barcelona Spain

2. Division of Allergy and Clinical Immunology; Bnai-Zion Medical Center; Haifa Israel

3. Salford Royal NHS Foundation Trust; Manchester Academic Health Science Center; University of Manchester; Manchester UK

4. Department of Dermatology and Allergy; Allergie-Centrum-Charité; Charité - Universitätsmedizin Berlin; Berlin Germany

Funder

Novartis Pharma AG

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Reference39 articles.

1. European Medicines Evaluation Agency (EMEA) Omalizumab (Xolair) summary of product characteristics (SmPC) 2014 http://www.ema.europa.eu

2. Genentech Inc Xolair: FDA Prescribing Information 2010 http://www.gene.com/download/pdf/xolair_prescribing.pdf

3. The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of urticaria. The 2013 revision and update;Zuberbier;Allergy,2014

4. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report;Maurer;Allergy,2011

5. Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care;Savic;Allergy Asthma Clin Immunol,2015
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3